Avidity Biosciences, Inc. announced on January 4, 2022, Joseph Baroldi informed the company of his intention to resign as Chief Operating Officer of the Company to pursue a new opportunity. His last day at the Company will be January 21, 2022. The Company has entered into a post-employment consulting agreement with Mr. Baroldi for a term of six months.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 USD | -0.74% | +3.73% | +229.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+229.17% | 283.28Cr | |
-1.62% | 8.92TCr | |
+2.24% | 4.05TCr | |
-13.82% | 3.28TCr | |
+63.43% | 2.62TCr | |
-21.19% | 1.45TCr | |
-7.92% | 1.31TCr | |
-42.60% | 1.16TCr | |
-12.64% | 1.15TCr | |
+5.47% | 881.83Cr |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences, Inc. Announces Resignation of Joseph Baroldi as Chief Operating Officer, Effective January 22, 2022